Clinical trials: Sclerosis, Progressive Systemic
- Condition Sclerosis, Progressive Systemic
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Healthy, Systemic Sclerosis
Systemic Sclerosis Clinical and Biomarker Study
The primary objective of the study is to assess the change in systemic sclerosis (SSc)-associated gastrointestinal (GI) tract symptoms over a 1-year period in participants with SSc.
- Trial name
- NCT02531009
- Volunteers
- healthy volunteers welcome
- Sponsor
- Biogen